THERAPEUTIC CLASS

The role of entecavir in the treatment of chronic hepatitis B

---

Entecavir (ETV) is a potent and selective inhibitor of hepatitis B virus replication. In HBeAg-positive and HBeAg-negative lamivudine-naïve patients with chronic hepatitis B (CHB), treatment with ETV at a dose of 0.5 mg daily is associated with a more potent viral suppression, a higher rate of biochemical remission and a greater improvement of liver histology
compared to Lamivudine (LAM).

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Atevir
Gastrointestinal & Hepatobiliary System

Specific Detail Info

Therapeutics and Clinical Risk Management 2007:3(6) 1077–1086

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment